Answers are grounded in this paper and cite their sources.
Bu2Sn(OPri)2's interaction with Schiff base (LaH), where La = L1 = OC6H4CH=NCNSC6H4 (1) and La = L2 = O2NC6H4CH=NCH2CH2O (2) yields the precursor derivatives Bu2Sn(La)(OPri), which on equimolar reaction with glycol (HOGOH), where G = G1 = OCH(Me)CH(Me)O, and G = G2 = OC(Me)2C(Me)2O, and diethanolamine RN(CH2CH2OH)2 yield the derivative of the type Bu2Sn(La)(LbH) [where La = L1, Lb = G1 (3); La = L1, Lb = G2 (4); La = L2, Lb = G1 (5); La = L2, Lb = G2 (6); La = L1, Lb = RN(CH2CH2O)2 where R=H(7); La = L1, Lb = RN(CH2CH2O)2 where R=CH3(8); La = L2, Lb = RN(CH2CH2O)2 where R=H(9); La = L2, Lb = RN(CH2CH2O)2 where R= CH3(10)]. Homometallic mixed ligand derivatives (3)-(10) on 1:1 reaction with aluminium isopropoxide form monomeric heterobimetallic mixed chelating ligand derivatives of type [Bu2Sn(La)(LbAl(OPri)2] (11)-(18) respectively. All these derivatives have been characterized by elemental analysis and spectroscopic [IR, NMR 1H, 119Sn, and 27Al ] studies. The synthesized derivatives were screened for their in vitro antimicrobial activity against gram +ve bacteria i.e.S.aureus and gram -ve bacteria i.e. E.Coli. All the derivatives showed enhanced antimicrobial activity than the present ligands.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: